
USFDA APPLICATION NUMBER - 203255 / DOSAGE - FOR SUSPENSION;INTRAMUSCULAR - EQ 20MG BASE/VIAL
Inactive Ingredients
| Ingredient Name | Novartis Pharmaceuticals Corporation  | 
					
|---|---|
| CARBOXYMETHYLCELLULOSE SODIUM(K679OBS311) | |
| MANNITOL(3OWL53L36A) | |
| POLOXAMER 188(LQA7B6G8JG) | |
| POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW)(WE369X5600) | |
| POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 63000 MW)(QD923V64H3) | |
| WATER(059QF0KO0R) |